Answers are grounded in this paper and cite their sources.
Cerebral toxoplasmosis is an important cause of intracranial mass lesions in patients with human immunodeficiency virus (HIV) infection and may be difficult to distinguish radiographically from primary central nervous system lymphoma (PCNSL). Although diffusion-weighted imaging may assist in the differential diagnosis, substantial overlap exists between these entities. We describe a 47-year-old man who presented with two weeks of progressive weakness beginning in the right lower extremity and subsequently progressing to profound bilateral lower-extremity weakness and generalized fatigue. Noncontrast computed tomography of the head demonstrated extensive vasogenic edema centered in the posterior left parietal lobe with compression of the left lateral ventricle and approximately 6 mm of midline shift. Magnetic resonance imaging (MRI) demonstrated multiple enhancing supratentorial lesions involving both cerebral hemispheres, including a dominant 3.9-cm left parietal lesion with extensive surrounding vasogenic edema and prominent restricted diffusion. Further evaluation revealed a new diagnosis of HIV with severe immunosuppression and a CD4 count of 26 cells/µL. Toxoplasma gondii serology demonstrated IgG greater than 400 IU/mL with negative IgM. Although cerebral toxoplasmosis was favored, PCNSL remained an important diagnostic consideration because of the marked diffusion restriction and absence of cerebrospinal fluid or tissue confirmation. Empiric trimethoprim-sulfamethoxazole therapy was initiated for a six-week course. Repeat MRI 15 days after initiation of therapy demonstrated interval reduction in the enhancing lesions, substantially decreased vasogenic edema, and improvement in associated mass effect, supporting a presumptive diagnosis of cerebral toxoplasmosis. This case highlights that prominent restricted diffusion does not exclude cerebral toxoplasmosis and emphasizes the importance of integrating immune status, lesion distribution, serologic findings, and response to empiric therapy when differentiating toxoplasmosis from PCNSL in patients with advanced HIV.
No takes yet. Share an insight, caveat, or question.
Malik et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: